A potential therapeutic effect of CYP2C8 overexpression on anti-TNF-α activity Corrigendum in /10.3892/ijmm.2023.5280

Liu,Wanjun; Wang,Bei; Ding,Hu; Wang,Dao  Wen; Zeng,Hesong

doi:10.3892/ijmm.2014.1844

A potential therapeutic effect of CYP2C8 overexpression on anti-TNF-α activity

Corrigendum in: /10.3892/ijmm.2023.5280

Authors:
- Wanjun Liu
- Bei Wang
- Hu Ding
- Dao Wen Wang
- Hesong Zeng
View Affiliations

Affiliations: The Institute of Hypertension and Department of Internal Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, P.R. China
Published online on: July 9, 2014 https://doi.org/10.3892/ijmm.2014.1844
Pages: 725-732
Copyright: © Liu et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY_NC 3.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Epoxyeicosatrienoic acids (EETs) are generated from arachidonic acid catalysed by cytochrome P450 (CYP) epoxygenases. In addition to regulating vascular tone EETs may alleviate inflammation and ROS. The present study was conducted to determine whether CYP2C8 gene overexpression was able to increase the level of EETs, and subsequently prevent TNF-α induced inflammation and reactive oxygen species (ROS) in human umbilical vein endothelial cells (HUVECs) and macrophages. Peroxisome proliferator‑activated receptor γ (PPARγ) activation, nuclear factor-κB (NF-κB) activation, endothelial nitric oxide synthase (eNOS) activation, gp-91 activation, and inflammatory cytokine expression were detected by western blot analysis or enzyme-linked immunosorbent assay. Intracellular reactive oxygen species (ROS) was measured by flow cytometry, while the migration of vascular smooth muscle cells (VSMCs) was detected by transwell assay. pCMV-mediated CYP2C8 overexpression and its metabolites, EETs, markedly suppressed TNF-α induced inflammatory cytokines IL-6 and MCP-1 expression via the activation of NF-κB and degradation of IκBα. Moreover, pretreatment with 11,12-EET significantly blocked TNF-α-induced ROS production. CYP2C8‑derived EETs also effectively alleviated the migration of VSMCs and improved the function of endothelial cells through the upregulation of eNOS, which was significantly decreased under the stimulation of TNF-α. Furthermore, these protective effects observed were mediated by PPARγ activation. To the best of our knowledge, the results of the present study demonstrated for the first time that CYP2C8-derived EETs exerted antivascular inflammatory and anti-oxidative effects, at least in part, through the activation of PPARγ. Thus, the CYP2C8 gene may be useful in the prevention and treatment of vascular inflammatory diseases.

View Figures

View References

1	Ross R: Atherosclerosis - an inflammatory disease. N Engl J Med. 340:115–126. 1999. View Article : Google Scholar
2	Guzik TJ, Korbut R and Adamek-Guzik T: Nitric oxide and superoxide in inflammation and immune regulation. J Physiol Pharmacol. 54:469–487. 2003.PubMed/NCBI
3	Cai H: Hydrogen peroxide regulation of endothelial function: origins, mechanisms, and consequences. Cardiovasc Res. 68:26–36. 2005. View Article : Google Scholar : PubMed/NCBI
4	Madamanchi NR, Hakim ZS and Runge MS: Oxidative stress in atherogenesis and arterial thrombosisthe disconnect between cellular studies and clinical outcomes. J Thromb Haemost. 3:254–267. 2005. View Article : Google Scholar : PubMed/NCBI
5	Forstermann U: Oxidative stress in vascular disease: causes, defense mechanisms and potential therapies. Nat Clin Pract Cardiovasc Med. 5:338–349. 2008. View Article : Google Scholar : PubMed/NCBI
6	Park JG and Oh GT: The role of peroxidases in the pathogenesis of atherosclerosis. BMB Rep. 44:497–505. 2011. View Article : Google Scholar
7	Cominacini L, Pasini AF, Garbin U, et al: Oxidized low density lipoprotein (ox-LDL) binding to ox-LDL receptor-1 in endothelial cells induces the activation of NF-κB through an increased production of intracellular reactive oxygen species. J Biol Chem. 275:12633–12638. 2000.
8	Miller YI, Viriyakosol S, Binder CJ, Feramisco JR, Kirkland TN and Witztum JL: Minimally modified LDL binds to CD14, induces macrophage spreading via TLR4/MD-2, and inhibits phagocytosis of apoptotic cells. J Biol Chem. 278:1561–1568. 2003. View Article : Google Scholar : PubMed/NCBI
9	Miller YI, Viriyakosol S, Worrall DS, Boullier A, Butler S and Witztum JL: Toll-like receptor 4-dependent and -independent cytokine secretion induced by minimally oxidized low-density lipoprotein in macrophages. Arterioscler Thromb Vasc Biol. 25:1213–1219. 2005. View Article : Google Scholar : PubMed/NCBI
10	Bae YS, Lee JH, Choi SH, et al: Macrophages generate reactive oxygen species in response to minimally oxidized low-density lipoprotein: toll-like receptor 4- and spleen tyrosine kinase-dependent activation of NADPH oxidase 2. Circ Res. 104:210–218. 2009. View Article : Google Scholar
11	Forman HJ and Torres M: Reactive oxygen species and cell signaling: respiratory burst in macrophage signaling. Am J Respir Crit Care Med. 166:S4–S8. 2002. View Article : Google Scholar : PubMed/NCBI
12	Taniyama Y and Griendling KK: Reactive oxygen species in the vasculature: molecular and cellular mechanisms. Hypertension. 42:1075–1081. 2003. View Article : Google Scholar : PubMed/NCBI
13	De Keulenaer GW, Ushio-Fukai M, Yin Q, et al: Convergence of redox-sensitive and mitogen-activated protein kinase signaling pathways in tumor necrosis factor-α-mediated monocyte chemoattractant protein-1 induction in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 20:385–391. 2000.PubMed/NCBI
14	Hulsmans M and Holvoet P: The vicious circle between oxidative stress and inflammation in atherosclerosis. J Cell Mol Med. 14:70–78. 2010. View Article : Google Scholar : PubMed/NCBI
15	Sury MD, Frese-Schaper M, Muhlemann MK, et al: Evidence that N-acetylcysteine inhibits TNF-α-induced cerebrovascular endothelin-1 upregulation via inhibition of mitogen- and stress-activated protein kinase. Free Radic Biol Med. 41:1372–1383. 2006.
16	Yang WS, Lee JM, Han NJ, Kim YJ, Chang JW and Park SK: Mycophenolic acid attenuates tumor necrosis factor-α-induced endothelin-1 production in human aortic endothelial cells. Atherosclerosis. 211:48–54. 2010.
17	Node K, Huo Y, Ruan X, et al: Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids. Science. 285:1276–1279. 1999. View Article : Google Scholar : PubMed/NCBI
18	Fisslthaler B, Popp R, Kiss L, et al: Cytochrome P450 2C is an EDHF synthase in coronary arteries. Nature. 401:493–497. 1999. View Article : Google Scholar : PubMed/NCBI
19	Wu S, Chen W, Murphy E, et al: Molecular cloning, expression, and functional significance of a cytochrome P450 highly expressed in rat heart myocytes. J Biol Chem. 272:12551–12559. 1997. View Article : Google Scholar : PubMed/NCBI
20	Zeldin DC, Foley J, Boyle JE, et al: Predominant expression of an arachidonate epoxygenase in islets of Langerhans cells in human and rat pancreas. Endocrinology. 138:1338–1346. 1997. View Article : Google Scholar : PubMed/NCBI
21	Michaelis UR, Fisslthaler B, Medhora M, Harder D, Fleming I and Busse R: Cytochrome P450 2C9-derived epoxyeicosatrienoic acids induce angiogenesis via cross-talk with the epidermal growth factor receptor (EGFR). FASEB J. 17:770–772. 2003.PubMed/NCBI
22	Sun J, Sui X, Bradbury JA, Zeldin DC, Conte MS and Liao JK: Inhibition of vascular smooth muscle cell migration by cytochrome p450 epoxygenase-derived eicosanoids. Circ Res. 90:1020–1027. 2002. View Article : Google Scholar : PubMed/NCBI
23	Liu L, Chen C, Gong W, et al: Epoxyeicosatrienoic acids attenuate reactive oxygen species level, mitochondrial dysfunction, caspase activation, and apoptosis in carcinoma cells treated with arsenic trioxide. J Pharmacol Exp Ther. 339:451–463. 2011. View Article : Google Scholar
24	Wray J and Bishop-Bailey D: Epoxygenases and peroxisome proliferator-activated receptors in mammalian vascular biology. Exp Physiol. 93:148–154. 2008. View Article : Google Scholar : PubMed/NCBI
25	Wu J, Chen C, Zeng HS and Wang DW: The protective effects of cytochrome P450 gene on atherosclerosis induced by high fat diet in different week old mice. Mol Cardiol Chin. 11:37–41. 2011.
26	Sun J, Huang SH, Zhu YC, et al: Anti-oxidative stress effects of Herba leonuri on ischemic rat hearts. Life Sci. 76:3043–3056. 2005. View Article : Google Scholar : PubMed/NCBI
27	Simoncini T, Maffei S, Basta G, et al: Estrogens and glucocorticoids inhibit endothelial vascular cell adhesion molecule-1 expression by different transcriptional mechanisms. Circ Res. 87:19–25. 2000. View Article : Google Scholar : PubMed/NCBI
28	Liu X, Pan L, Gong Q and Zhu Y: Leonurine (SCM-198) improves cardiac recovery in rat during chronic infarction. Eur J Pharmacol. 649:236–241. 2010. View Article : Google Scholar
29	Wilson SH, Best PJ, Edwards WD, et al: Nuclear factor-κB immunoreactivity is present in human coronary plaque and enhanced in patients with unstable angina pectoris. Atherosclerosis. 160:147–153. 2002.
30	Collins T and Cybulsky MI: NF-κB: pivotal mediator or innocent bystander in atherogenesis? J Clin Invest. 107:255–264. 2001.
31	Brasier AR: The nuclear factor-κB-interleukin-6 signalling pathway mediating vascular inflammation. Cardiovasc Res. 86:211–218. 2010.
32	Marx N, Duez H, Fruchart JC and Staels B: Peroxisome proliferator-activated receptors and atherogenesis: regulators of gene expression in vascular cells. Circ Res. 94:1168–1178. 2004. View Article : Google Scholar : PubMed/NCBI
33	Ricote M, Li AC, Willson TM, Kelly CJ and Glass CK: The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation. Nature. 391:79–82. 1998.
34	Cipollone F, Fazia M, Iezzi A, et al: Balance between PGD synthase and PGE synthase is a major determinant of atherosclerotic plaque instability in humans. Arterioscler Thromb Vasc Biol. 24:1259–1265. 2004. View Article : Google Scholar
35	Dehmer T, Heneka MT, Sastre M, Dichgans J and Schulz JB: Protection by pioglitazone in the MPTP model of Parkinson’s disease correlates with IκBα induction and block of NF κB and iNOS activation. J Neurochem. 88:494–501. 2004.PubMed/NCBI
36	Castrillo A and Tontonoz P: PPARs in atherosclerosis: the clot thickens. J Clin Invest. 114:1538–1540. 2004. View Article : Google Scholar : PubMed/NCBI
37	Wang H, Lin L, Jiang J, et al: Up-regulation of endothelial nitric-oxide synthase by endothelium-derived hyperpolarizing factor involves mitogen-activated protein kinase and protein kinase C signaling pathways. J Pharmacol Exp Ther. 307:753–764. 2003. View Article : Google Scholar
38	Lee PC, Ho IC and Lee TC: Oxidative stress mediates sodium arsenite-induced expression of heme oxygenase-1, monocyte chemoattractant protein-1, and interleukin-6 in vascular smooth muscle cells. Toxicol Sci. 85:541–550. 2005. View Article : Google Scholar
39	Zhang T, Zhang X, Yu W, et al: Effects of chemokine-like factor 1 on vascular smooth muscle cell migration and proliferation in vascular inflammation. Atherosclerosis. 226:49–57. 2013. View Article : Google Scholar : PubMed/NCBI
40	Caglayan E, Romeo GR, Kappert K, et al: Profilin-1 is expressed in human atherosclerotic plaques and induces atherogenic effects on vascular smooth muscle cells. PLoS One. 5:e136082010. View Article : Google Scholar : PubMed/NCBI
41	Nakagawa M, Ohno T, Maruyama R, et al: Sesquiterpene lactone suppresses vascular smooth muscle cell proliferation and migration via inhibition of cell cycle progression. Biol Pharm Bull. 30:1754–1757. 2007. View Article : Google Scholar : PubMed/NCBI